Concord Drugs Ltd Share Price
(538965)
₹33.9▲2.36%
as on 11:39AM, 21 Feb 2025
Day's Low
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -13.46 % |
3 Month Return | -7.33 % |
1 Year Return | -17.59 % |
Market Stats | |
Previous Close | ₹33.12 |
Open | ₹33.90 |
Volume | 870.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹33.12Cr |
P/E Ratio
-828
PEG Ratio
752.73
Market Cap
₹33.12 Cr
P/B Ratio
1.04
EPS
0.47
Dividend Yield
0Sector
Pharmaceuticals
ROE
1.28
Key events for Concord Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 4 quarters, -0.34 Cr → 0.23 Cr (in ₹), with an average increase of 447.0% per quarter
Price Rise
In the last 7 days, Concord Drugs stock has moved up by 2.6%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 45.61% of holdings in Dec 2024 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.39% of holdings in Dec 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 63.8% return, outperforming this stock by 81.4%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.2% return, outperforming this stock by 122.3%
Revenue Fall
Revenue is down for the last 2 quarters, 12.37 Cr → 10.8 Cr (in ₹), with an average decrease of 12.7% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 54.39% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 45.61% | 0.00 | |
Others | 0% | 0.00 |
Concord Drugs Ltd in the last 5 years
Lowest (-961.50x)
January 3, 2025
Today (-828.00x)
February 20, 2025
Industry (51.76x)
February 20, 2025
Highest (791.40x)
July 3, 2024
Concord Drugs Ltd’s net profit jumped 195.83% since last year same period to ₹0.23Cr in the Q3 2024-2025. On a quarterly growth basis, Concord Drugs Ltd has generated 475% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Concord Drugs Ltd is currently in a Neutral trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹33.12 Cr | 23.58% | 0.67 | ₹1 Cr | ₹44 Cr | |
NA | ₹686.80 Cr | 124.79% | 0.91 | ₹55 Cr | ₹575 Cr | |
NA | ₹103.20 Cr | 31.27% | 0.55 | NA | NA | |
NA | ₹671.21 Cr | 28.67% | 0.69 | ₹5 Cr | ₹1,684 Cr | |
NA | ₹98.19 Cr | 37.72% | 0.73 | NA | NA |
Organisation | Concord Drugs Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Concord Drugs Ltd share price today stands at ₹33.9, Open: ₹33.9, Previous Close: ₹33.12, High: ₹33.9, Low: ₹33.12, 52 Week High: ₹44.96, 52 Week Low: ₹28.5.
Concord Drugs Ltd is not listed on NSE
Concord Drugs Ltd is listed on BSE
Today's traded volume of Concord Drugs Ltd(538965) is 870.00.
Today's market capitalisation of Concord Drugs Ltd(538965) is ₹33.12Cr.
Concord Drugs Ltd (538965) share price is ₹33.9. It is down -24.60% from its 52 Week High price of ₹44.96
Concord Drugs Ltd (538965) share price is ₹33.9. It is up 18.95% from its 52 Week Low price of ₹28.5
PE Ratio of Concord Drugs Ltd is -828
PE ratio = Concord Drugs Ltd Market price per share / Concord Drugs Ltd Earnings per share